Skip Navigation

Perceptions of HIV patients also taking antimalarials

"Every drug goes to treat its own disease": read the latest ACT Consortium paper, in the Malaria Journal, on how HIV patients in Tanzania perceive antimalarial treatment when taken together with antiretrovirals.

News from our Partners

An independent review examined the impact of Roll Back Malaria control campaigns on primary school education in 14 sub-Saharan African countries. The campaign reveals itself as a cost-effective strategy to improve children's educational attainment.

Multimedia section

Watch videos, browse a prezi and listen to podcasts with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

Malaria research publications

Browse through more than 70 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.